Daniel Fornika
Overview
Explore the profile of Daniel Fornika including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alcaide M, Yu S, Davidson J, Albuquerque M, Bushell K, Fornika D, et al.
Sci Rep
. 2017 Sep;
7(1):10574.
PMID: 28874686
Ultrasensitive methods for rare allele detection are critical to leverage the full potential offered by liquid biopsies. Here, we describe a novel molecular barcoding method for the precise detection and...
2.
Dewar L, Alcaide M, Fornika D, DAmato L, Shafaatalab S, Stevens C, et al.
Circ Cardiovasc Genet
. 2017 Aug;
10(4).
PMID: 28807990
Background: Inherited arrhythmia syndromes are responsible for a significant portion of autopsy-negative sudden unexpected death (SUD) cases, but molecular autopsy used to identify potentially causal variants is not routinely included...
3.
Alcaide M, Yu S, Bushell K, Fornika D, Nielsen J, Nelson B, et al.
Clin Chem
. 2016 Jul;
62(9):1238-47.
PMID: 27440511
Background: A plethora of options to detect mutations in tumor-derived DNA currently exist but each suffers limitations in analytical sensitivity, cost, or scalability. Droplet digital PCR (ddPCR) is an appealing...
4.
Assouline S, Nielsen T, Yu S, Alcaide M, Chong L, MacDonald D, et al.
Blood
. 2016 May;
128(2):185-94.
PMID: 27166360
The majority of diffuse large B-cell lymphoma (DLBCL) tumors contain mutations in histone-modifying enzymes (HMEs), indicating a potential therapeutic benefit of histone deacetylase inhibitors (HDIs), and preclinical data suggest that...
5.
Morin R, Assouline S, Alcaide M, Mohajeri A, Johnston R, Chong L, et al.
Clin Cancer Res
. 2015 Dec;
22(9):2290-300.
PMID: 26647218
Purpose: Relapsed or refractory diffuse large B-cell lymphoma (rrDLBCL) is fatal in 90% of patients, and yet little is known about its biology. Experimental Design: Using exome sequencing, we characterized...
6.
Bushell K, Kim Y, Chan F, Ben-Neriah S, Jenks A, Alcaide M, et al.
Blood
. 2014 Dec;
125(6):999-1005.
PMID: 25468570
Non-Hodgkin lymphomas (NHLs) are the most common cancer to affect pet dogs. In contrast to the many genes whose mutation contributes to lymphomagenesis in humans, relatively little is known about...
7.
Moore R, Ogilvie G, Fornika D, Moravan V, Brisson M, Amirabbasi-Beik M, et al.
Cancer Causes Control
. 2009 May;
20(8):1387-96.
PMID: 19475481
Background: Human papilloma virus (HPV) prevalence studies performed in different regions and population groups across Canada would inform public health decisions regarding implementation of anti-HPV vaccines. Methods: A total of...